Cladribine and low-dose cytarabine alternating with decitabine as front-line therapy for elderly patients with acute myeloid leukaemia: a phase 2 single-arm trial

Tapan M. Kadia, Jorge Cortes, Farhad Ravandi, Elias Jabbour, Marina Konopleva, Christopher B. Benton, Jan Burger, Koji Sasaki, Gautam Borthakur, Courtney D. DiNardo, Naveen Pemmaraju, Naval Daver, Alessandra Ferrajoli, Xuemei Wang, Keyur Patel, Jeffrey L. Jorgensen, Sa Wang, Susan O'Brien, Sherry Pierce, Carla TuttleZeev Estrov, Srdan Verstovsek, Guillermo Garcia-Manero, Hagop Kantarjian

Research output: Contribution to journalArticlepeer-review

69 Scopus citations

Fingerprint

Dive into the research topics of 'Cladribine and low-dose cytarabine alternating with decitabine as front-line therapy for elderly patients with acute myeloid leukaemia: a phase 2 single-arm trial'. Together they form a unique fingerprint.

Medicine & Life Sciences